Automated Antimicrobial Susceptibility Testing Market Report to Exhibits a Stunning Growth Potentials with High CAGR by 2030 | Creative Diagnostics, Resistell AG, Danaher Corporation

Automated Antimicrobial Susceptibility Testing Market: Empowering Business Professionals and Driving Innovation

The Automated Antimicrobial Susceptibility Testing Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Automated antimicrobial susceptibility testing (AST) helps determine the sensitivity of microorganisms to different antibiotics. It plays a key role in optimizing therapy for infectious diseases in clinical microbiology laboratories.

Market Dynamics:

The Automated Antimicrobial Susceptibility Testing Market is expected to witness significant growth over the forecast period owing to the rising incidence of hospital acquired infections and growing need for rapid detection of drug-resistant microorganisms. According to the Centers for Disease Control and Prevention, over 2.8 million hospitalized patients in the U.S. develop hospital-acquired infections each year and more than 35,000 Americans die as a result. Moreover, growing adoption of advanced systems that provide accurate and fast results and minimize errors is also expected to support the market growth during this period. However, high costs associated with automated systems may hinder market growth.

The report offers a '110+ Pages' thorough expert analysis of the present state of the keyword market. Among the market data evaluated and re-validated in the study are CAGR, gross margin, revenue, price, production growth rate, volume, value, market share, and year-over-year growth. The most up-to-date primary and secondary research approaches were used to construct this comprehensive Automated Antimicrobial Susceptibility Testing Market report.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2622

𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 𝐎𝐟 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟑 𝐈𝐧𝐜𝐥𝐮𝐝𝐞𝐬:

🠺 Brief Introduction to the research report.
🠺 Table of Contents (Scope covered as a part of the study)
🠺 Top players in the market
🠺 Research framework (structure of the report)
🠺 Research methodology adopted by Coherent Market Insights

Major companies in Automated Antimicrobial Susceptibility Testing Market are:

bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

Increasing prevalence of hospital-acquired infections pushing demand

Hospital-acquired or nosocomial infections remain a major healthcare problem affecting millions annually. The high transmission rate of drug-resistant bacteria in healthcare settings has complicated the treatment of nosocomial infections. Automated AST systems assist effective management of device-associated and surgical site infections by facilitating prompt antimicrobial susceptibility profiling. They aid selection of appropriate empiric antibiotic therapy for susceptible pathogens. This helps curb mortality and reduce unnecessary antibiotic usage associated with hospital-acquired infections. With their deployment across hospitals, automated solutions help address the growing threat of multi-drug resistant organisms acquired in medical facilities.

Stringent regulatory standards raising compliance burden

Regulatory standards for antimicrobial susceptibility testing are continuously evolving to align with contemporary diagnostic needs. Manufacturers must comply with additional performance criteria and quality requirements specified by regulatory agencies to introduce automated systems. For instance, the FDA requires extensive clinical trials and validations as per standards set by organizations like CLSI before new AST devices can be marketed. Complying with changing regulations necessitates sizable R&D investments and protracted product approval timelines. Furthermore, rigorous performance evaluation drives up the per-test costs of automated solutions. The compliance challenges and expenses associated with evolving quality norms can hamper the entry of cost-effective automated systems especially in price-sensitive markets.

Market Segmentation:

By Product Type (Consumables and Instruments)

By Detection Method (Turbidimetric and Colorimetric)

By Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral)

By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories)

Buy Now and Get a Discount on this Report @ https://www.coherentmarketinsights.com/insight/buy-now/2622

Scope for AI-based diagnostic solutions to address skilled workforce shortage

Antimicrobial susceptibility testing relies on skilled microbiologists and technical staff for operations and interpretion of test results. However, there is a rising shortage of qualified clinical laboratory professionals worldwide which threatens the timely and accurate reporting of AST results. Advanced AI and machine learning techniques now enable development of fully-automated, intelligent diagnostic platforms requiring minimal human intervention. AI-powered diagnostic modules can automate task like bacterial identification, antibiogram generation and result validation. This helps address the workforce challenges in clinical microbiology. With their ability to analyze huge volumes of phenotypic and genomic data, AI-driven solutions can deliver rapid, standardized and accurate AST reporting. This presents lucrative growth opportunities for automated systems integrated with AI/ML capabilities.

Increasing preference for rapid diagnostic techniques

The COVID-19 pandemic accentuated the need for prompt infectious disease diagnostics to expedite treatment initiation and curb spread. It highlighted the importance of automated platforms capable of delivering test results within hours compared to conventional methods. Furthermore, the pandemic increased awareness about AMR diagnosis and surveillance among healthcare providers and regulators. This has prompted greater focus on rapid AST methods over culture-based techniques. Manufacturers are witnessing rising demand for automated susceptibility testing systems integrated with modular, Random-Access designs supporting STAT testing on demand. The growing preference for same-day diagnostics is expected to boost technological advancements in automated AST solutions. Their ability to deliver actionable reports rapidly without delay remains an attractive value proposition.

Geographical Analysis:

🠺 North America (United States, Canada and Mexico)
🠺 Europe (Germany, France, UK, Russia and Italy)
🠺 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
🠺 Latin America (Brazil, Argentina, Colombia etc.)
🠺 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

The Automated Antimicrobial Susceptibility Testing Market report compiles data from Primary sources involves conducting extensive interviews with industry experts and key opinion leaders, such as CEOs, marketing executives, experienced front-line staff, downstream distributors, and end-users. On the other hand, secondary sources involve analysing annual and financial reports of top companies, public files, news journals, and other relevant sources. Additionally, we collaborate with third-party databases to ensure comprehensive and accurate data.

These are the Reasons to Invest in this Report:

✔ Automated Antimicrobial Susceptibility Testing Market provides an analysis of the changing competitive environment
✔ Analytical data and strategic planning methods are involved to help businesses make informed decisions.
✔ Few year assessment for Automated Antimicrobial Susceptibility Testing Market.
✔ It allows you to understand the key product segments.
✔ Our team shed light on market dynamics such as drivers and restraints, trends and opportunities.
✔ It provides a regional analysis of the Automated Antimicrobial Susceptibility Testing Market as well as business profiles for several stakeholders.
✔ It provides massive data on trending factors that can influence the development of the Automated Antimicrobial Susceptibility Testing Market.

Get customized report as per requirement @ https://www.coherentmarketinsights.com/insight/request-customization/2622

Expanding the Market:

The Automated Antimicrobial Susceptibility Testing market has strategically focused on expanding its market presence and customer base. By partnering with technology leaders, they aim to tap into new markets and extend their influence globally. This collaborative approach allows the Automated Antimicrobial Susceptibility Testing industry to combine their resources, knowledge, and networks, resulting in mutually beneficial outcomes for all stakeholders involved

📌Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.